About Index Trending news
Analyze
Pricing
Amgen Inc.

Amgen Inc.

Work at Amgen Inc.? Add yourself to this profile

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Total funding
$66.5M in 3 rounds from 12 investors
By Amgen Ventures
$29M Series C in Apr, 2017
Total funding
$42.4M in 2 rounds from 5 investors
By Amgen Ventures
$11.9M Series B in Jul, 2016
Total funding
$60.5M in 4 rounds from 18 investors
By Amgen Ventures
$8.5M Series C in Feb, 2015
Total funding
$95.2M in 8 rounds from 18 investors
By Amgen Ventures
undisclosed deal in Jul, 2005
Total funding
$52M in 2 rounds from 13 investors
By Amgen Ventures
$13.5M Series B in Jan, 2014
Total funding
$29.5M in 1 rounds from 9 investors
By Amgen Ventures
$29.5M Series D in Jan, 2016
Total funding
$43M in 1 rounds from 7 investors
By Amgen Ventures
$43M Series B in Mar, 2016

Want to see the complete list?
Go Pro!